These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26672759)

  • 21. The role of depression severity in the cognitive functioning of elderly subjects with central nervous system disease.
    van Reekum R; Simard M; Clarke D; Conn D; Cohen T; Wong J
    J Psychiatry Neurosci; 2000 May; 25(3):262-8. PubMed ID: 10863886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pupillary dysfunction of multiple system atrophy: Dynamic pupillometric findings and clinical correlations.
    Park KW; Choi N; Ryu HS; Kim MS; Lee EJ; Chung SJ
    Parkinsonism Relat Disord; 2019 Aug; 65():234-237. PubMed ID: 31076267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Relationship of Symptoms of Anxiety and Depression with Disease Severity and Treatment Modality in Myasthenia Gravis: A Cross-sectional Study.
    Aysal F; Karamustafalioğlu O; Özçelik B; Yilmaz M; Karamustafalioğlu N; Yumrukçal H; Tankaya O
    Noro Psikiyatr Ars; 2013 Dec; 50(4):295-300. PubMed ID: 28360560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Central acetylcholine receptor function in patients with myasthenia gravis].
    Watanabe S; Shimazu K; Tamura N; Yamamoto T; Hamaguchi K
    Rinsho Shinkeigaku; 1991 Feb; 31(2):170-4. PubMed ID: 2060241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunctional chemosensation in myasthenia gravis: a systematic review.
    Leon-Sarmiento FE; Leon-Ariza DS; Doty RL
    J Clin Neuromuscul Dis; 2013 Sep; 15(1):1-6. PubMed ID: 23965402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in psychophysiological processing of vision in myasthenia gravis.
    Fotiou F; Goulas A; Fountoulakis K; Koutlas E; Hamlatzis P; Papakostopoulos D
    Int J Psychophysiol; 1998 Aug; 29(3):303-10. PubMed ID: 9666383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychiatric and functional neuroimaging abnormalities in chronic hepatitis C virus patients: Is vasculitis a contributing factor?
    Zayed HS; Amin A; Alsirafy S; Elsayed ND; Abo Elfadl S; Nasreldin M; Enaba D; Nawito Z
    Arab J Gastroenterol; 2018 Jun; 19(2):71-75. PubMed ID: 29935864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myasthenia gravis: myasthenia vs. cholinergic crisis.
    Hetherington KA; Losek JD
    Pediatr Emerg Care; 2005 Aug; 21(8):546-8; quiz 549-51. PubMed ID: 16096606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenia gravis with autoimmune autonomic neuropathy.
    Vernino S; Cheshire WP; Lennon VA
    Auton Neurosci; 2001 May; 88(3):187-92. PubMed ID: 11474561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive evaluation of sudomotor function in patients with myasthenia gravis.
    Falcão de Campos C; Viana P; de Castro I; Castro J; de Carvalho M; Conceição I
    Neurophysiol Clin; 2019 Feb; 49(1):81-86. PubMed ID: 30554965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a central cholinergic deficit in myasthenia gravis.
    Fotiou F; Fountoulakis KN
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):514-5. PubMed ID: 11083171
    [No Abstract]   [Full Text] [Related]  

  • 33. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes.
    Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T
    Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perception of dreams and subjective sleep quality in patients with myasthenia gravis.
    Happe S; Klösch G; Zeitlhofer J
    Neuropsychobiology; 2004; 50(1):21-7. PubMed ID: 15179016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac autonomic control in patients with myasthenia gravis and thymoma.
    Peric S; Rakocevic-Stojanovic V; Nisic T; Pavlovic S; Basta I; Popovic S; Damjanovic S; Lavrnic D
    J Neurol Sci; 2011 Aug; 307(1-2):30-3. PubMed ID: 21658726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cardiac autonomic functions in myasthenia gravis.
    Kocabas ZU; Kizilay F; Basarici I; Uysal H
    Neurol Res; 2018 May; 40(5):405-412. PubMed ID: 29607742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotoxic impact of mercury on the central nervous system evaluated by neuropsychological tests and on the autonomic nervous system evaluated by dynamic pupillometry.
    Milioni ALV; Nagy BV; Moura ALA; Zachi EC; Barboni MTS; Ventura DF
    Neurotoxicology; 2017 Mar; 59():263-269. PubMed ID: 27090823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.
    Motter JN; Pelton GH; D'Antonio K; Rushia SN; Pimontel MA; Petrella JR; Garcon E; Ciovacco MW; Sneed JR; Doraiswamy PM; Devanand DP
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1604-1612. PubMed ID: 30035339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects.
    Koller D; Belmonte C; Lubomirov R; Saiz-Rodríguez M; Zubiaur P; Román M; Ochoa D; Carcas A; Wojnicz A; Abad-Santos F
    J Psychopharmacol; 2018 Nov; 32(11):1212-1222. PubMed ID: 30251598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.